Similar articles

• [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].

  de Lange DW, Fiets WE, Banga JD. de Lange DW, et al. Ned Tijdschr Geneeskd. 2004 Jul 24;148(30):1481-5. Ned Tijdschr Geneeskd. 2004. PMID: 15481570 Review. Dutch.
• [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].

  Klomp CM, ten Cate H, Stehouwer CD, Schaper NC. Klomp CM, et al. Ned Tijdschr Geneeskd. 2009;153:A109. Ned Tijdschr Geneeskd. 2009. PMID: 19785798 Review. Dutch.
• Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.

  Bruno A, Grassi G, Dani F, Degiovanni M, Maghenzani G, Pagano G. Bruno A, et al. Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):42-6. doi: 10.1016/j.numecd.2004.04.001. Nutr Metab Cardiovasc Dis. 2005. PMID: 15871850
• [Aspirin use in patients with diabetes mellitus].

  Sicras Mainar A, Ruiz Riera R, Frías Garrido X, Navarro Artieda R. Sicras Mainar A, et al. Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239. Med Clin (Barc). 2004. PMID: 15282081 Spanish. No abstract available.
• [Should we treat all diabetic patients with aspirin in primary prevention?].

  Righetti A, De Moerloose P, Philippe J. Righetti A, et al. Rev Med Suisse. 2005 Jun 1;1(22):1500-4. Rev Med Suisse. 2005. PMID: 16025889 Review. French.